SAM
PFE icon

Sagewood Asset Management’s Pfizer PFE Stock Holding History

Sagewood Asset Management’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$364K Buy
15,105
+165
+1% +$4.32K 0.08% 253
2026
Q1 		$420K Buy
14,940
+1,095
+8% +$29.2K 0.13% 153
2025
Q4 		$345K Buy
+13,845
New +$349K 0.12% 150

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Sagewood Asset Management's PFE Position: Q2 2026 in Review

Sagewood Asset Management increased its Pfizer (PFE) stake by 1.1% in Q2 2026, buying an estimated $4.32K and bringing the position to 15,105 shares worth $364K. The position accounts for 0.08% of the portfolio, ranked #253.

Sagewood Asset Management first reported a position in PFE in Q4 2025 and has held it in 3 quarters since. The position peaked at $420K in Q1 2026. 2,822 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Sagewood Asset Management held 15,105 shares of Pfizer worth $364K as of Q2 2026.
  • Sagewood Asset Management bought 165 Pfizer shares in Q2 2026, an estimated $4.32K.
  • Pfizer made up 0.08% of Sagewood Asset Management's portfolio in Q2 2026, its #253 holding.
  • Sagewood Asset Management first reported a position in Pfizer in Q4 2025 and has held it in 3 quarters since.
  • Sagewood Asset Management's Pfizer position peaked at $420K in Q1 2026.
  • 2,822 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Sagewood Asset Management's 13F filing for Q2 2026, filed 29 Jul 2026.